LYEL
#3173
Lyell Immunopharma, Inc. - Common Stock
14.5 2 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.62%
Monthly Change
+12.56%
6 month change
-39.20%
Year Change
-39.98%
Previous Close
14.6 1
Open
14.4 8
Low
14.4 7
High
14.5 9
Volume
41
Financials
- Market Capitalization 355.81 M
- Employee 161
- Founded 2018
- CEO N/A
- Website www.lyell.com
- Headquarter Delaware, United States
- FIGI BBG00RNXFN14
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.92
Price to sales ratio
14.61 K
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3143 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.03 USD | -8.97% | -2.40% | -0.49% | +298.04% | 367.58 M USD | ||
| 3172 |  FHTX Foghorn Therapeutics Inc. - Common Stock | 6.00 USD | -3.54% | -15.13% | +16.73% | +47.06% | 356.31 M USD | ||
| 3188 |  PALI Palisade Bio, Inc. - Common Stock | 2.01 USD | -4.74% | -4.29% | -0.50% | +18.24% | 350.28 M USD | ||
| 3199 |  SABS SAB Biotherapeutics, Inc. - Common Stock | 3.79 USD | -3.56% | +1.07% | +10.50% | +80.48% | 344.84 M USD |
Frequently asked questions about Lyell Immunopharma, Inc. Common Stock
What is the Lyell Immunopharma, Inc. Common Stock stock price today?
The current price of Lyell Immunopharma, Inc. Common Stock (LYEL) is 14.52. Over the past 24 hours, the stock has changed by -0.62%. Follow the LYEL chart for real-time price dynamics.
What is the stock ticker of Lyell Immunopharma, Inc. Common Stock?
Lyell Immunopharma, Inc. Common Stock trades under the ticker LYEL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Lyell Immunopharma, Inc. Common Stock stock going up?
LYEL has changed by -6.50% over the last week, +12.56% over the last month, and -39.98% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Lyell Immunopharma, Inc. Common Stock?
Lyell Immunopharma, Inc. Common Stock currently has a market capitalization of 355.81 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Lyell Immunopharma, Inc. Common Stock earnings last quarter?
Last quarter, Lyell Immunopharma, Inc. Common Stock reported earnings of -1.92 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Lyell Immunopharma, Inc. Common Stock revenue for the last quarter?
Lyell Immunopharma, Inc. Common Stock reported quarterly revenue of 4 000. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Lyell Immunopharma, Inc. Common Stock net income for the last quarter?
Lyell Immunopharma, Inc. Common Stock reported net income of -44.76 M for the last quarter. The previous quarter showed -24.15 M, which means net income changed by -85.30%.
How many employees does Lyell Immunopharma, Inc. Common Stock have?
As of the latest available data, Lyell Immunopharma, Inc. Common Stock has 161 employees. Workforce size can provide additional context about the company's scale and operations.
What is Lyell Immunopharma, Inc. Common Stock EBITDA?
Lyell Immunopharma, Inc. Common Stock EBITDA is -45.12 M, and its EBITDA margin is -1.13 M%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Lyell Immunopharma, Inc. Common Stock stock?
You can buy Lyell Immunopharma, Inc. Common Stock (LYEL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Lyell Immunopharma, Inc. Common Stock stock?
Investing in Lyell Immunopharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LYEL chart and related analysis on metatrader.com as part of your research.